Stock Data
$0.00 (0.00%)
Asset Type
N/A
Exchange
N/A
Currency
N/A
Country
N/A
Sector
N/A
Industry
N/A
Crinetics Pharmaceuticals Inc is a pioneering clinical-stage pharmaceutical company based in San Diego, California, dedicated to crafting innovative treatments for rare endocrine diseases and endocrine-related tumors. With a focus on oral, nonpeptide therapies, its flagship product, paltusotine, is advancing through clinical trials targeting conditions like acromegaly and carcinoid syndrome. Additionally, Crinetics is exploring treatments for diseases caused by excess ACTH, primary hyperparathyroidism, and other endocrine disorders, aiming to address unmet medical needs with novel therapeutics.
Vertex's $85.00 per share all-cash deal, expected to close this quarter, now looks locked in as PALSONIFY's net product revenue more than doubled to $24.0 million. Guidance is withdrawn and there is no earnings call, so the merger vote is the only catalyst left.
2 Articles
Our top personal finance-related articles today. Your wallet will thank you later.
